APA ציטוט

Lam, L. H., Capparelli, E. V., & Kurzrock, R. (2016). Association of concurrent acid-suppression therapy with survival outcomes and adverse event incidence in oncology patients receiving erlotinib. Cancer Chemother Pharmacol.

Citação norma Chicago

Lam, Lisa H., Edmund V. Capparelli, and Razelle Kurzrock. "Association of Concurrent Acid-suppression Therapy With Survival Outcomes and Adverse Event Incidence in Oncology Patients Receiving Erlotinib." Cancer Chemother Pharmacol 2016.

ציטוט MLA

Lam, Lisa H., Edmund V. Capparelli, and Razelle Kurzrock. "Association of Concurrent Acid-suppression Therapy With Survival Outcomes and Adverse Event Incidence in Oncology Patients Receiving Erlotinib." Cancer Chemother Pharmacol 2016.